1. Adams CP, von Brantner V (2006) Estimation of the costs of new drug development: is it really $802 million? Health Aff 25(2):423
2. Cornish WR, Llewelyn D (2003) Intellectual property: patents, copyright, trade marks and allied rights. Sweet & Maxwell, London
3. Depo B (2004) “Specific Criteria in Determining Likelihood of Confusion in Relation to Pharmaceutical Products”, 4 StoffR 192
4. Mellor J, Llewelyn D, Moody-Stuart T, Keeling D, Berkley I (2011) Kerly’s law of trade marks and trade names. Sweet & Maxwell, London, p 360
5. Micheletti CT (2004) Preventing loss of trademark rights: quantitative and qualitative assessments of ‘use’ and their impact on abandonment determinations. TMR 5:634–636